AOHC Press Release: Additional doses of COVID-19 Vaccine for Immunocompromised Individuals

Posted on:

This press release was developed by an AOHC Public Health Preparedness Committee (BTeam) workgroup.

On August 13, the U.S. Food and Drug Administration (FDA) and the Centers for Disease Control and Prevention (CDC) advised that an additional, or third dose, of messenger RNA (mRNA) Covid-19 vaccine could be given to people who are immunocompromised (have weakened immune systems) and have already received two doses of either Moderna or Pfizer vaccine.

3rd dose AOHC communication final 8-19-21